BRIEF-EU Medicines Agency recommends approval of two new cancer drugs By: Reuters: Company News July 22, 2016 at 07:21 AM EDT * Recommends approval of Exelixis Inc'S cabozantinib to treat advanced renal cell carcinoma Read More >> Related Stocks: Baxter International Exelixis Inc